Aspirin can reduce arthritis pain and inflammation, but it’s no longer a first-choice treatment for most people with joint disease. While it was once widely used for arthritis at high doses, newer anti-inflammatory options have largely replaced it because they offer similar relief with fewer side effects, particularly less risk of stomach bleeding.
That said, aspirin still has some interesting properties that set it apart, and whether it makes sense for you depends on the type of arthritis you have, what other medications you take, and how your kidneys and stomach are holding up.
How Aspirin Works on Joint Inflammation
Aspirin belongs to the same family of anti-inflammatory drugs as ibuprofen and naproxen. It works by blocking two enzymes (COX-1 and COX-2) that your body uses to produce prostaglandins, the chemical messengers responsible for pain, swelling, and inflammation in your joints. What makes aspirin unique is that it blocks these enzymes permanently rather than temporarily. Each dose irreversibly shuts down the enzymes in the cells it reaches, so the effect lasts until your body produces new ones.
Aspirin also triggers an unusual anti-inflammatory pathway that other painkillers don’t. When it modifies the COX-2 enzyme, the enzyme starts producing a specialized lipid molecule that actively slows down the recruitment of immune cells to inflamed tissue. This means aspirin doesn’t just block inflammation signals; it also generates a “braking signal” that helps cool down the inflammatory response at the cellular level.
Aspirin and Osteoarthritis
For osteoarthritis, the wear-and-tear form that affects most people as they age, aspirin provides modest pain relief comparable to other over-the-counter anti-inflammatories. It’s not stronger or faster acting than ibuprofen or naproxen, which is one reason it’s fallen out of favor for this use.
One intriguing finding, though, comes from a cohort study of people with knee osteoarthritis. Regular aspirin users lost cartilage in their knee joints at roughly half the rate of non-users: 1.9% annual cartilage loss compared to 5.4%. That’s a significant difference, roughly 50% less cartilage breakdown over two years. This was an observational study, not a controlled trial, so it doesn’t prove aspirin caused the protection. But it raises the possibility that aspirin’s anti-inflammatory effects may do more than mask symptoms.
Aspirin and Rheumatoid Arthritis
For rheumatoid arthritis, an autoimmune condition where the immune system attacks the joints, aspirin alone isn’t enough. The inflammation in RA is driven by immune dysfunction that requires disease-modifying drugs to control. Aspirin might take the edge off pain, but it won’t slow the joint damage the way targeted RA treatments can.
There’s also an important interaction to be aware of. If you’re taking methotrexate, one of the most common RA medications, aspirin at pain-relief doses can interfere with how your kidneys clear methotrexate from your body. This raises the risk of methotrexate building up to toxic levels. Low-dose aspirin taken for heart protection (typically 75 to 100 mg) is generally considered safe alongside methotrexate, but higher analgesic doses should only be combined under a specialist’s guidance.
Dosing for Pain Relief
When used for arthritis pain rather than heart protection, aspirin is taken at much higher doses. The typical pain-relief dose is 300 to 600 mg every four to six hours, with a maximum of 3,600 mg (twelve 300 mg tablets) in 24 hours. This is dramatically more than the 75 to 100 mg daily dose used for cardiovascular protection, and the higher dose is where most of the side effect concerns come in.
At these levels, aspirin acts as a full anti-inflammatory drug on your body, including your kidneys and stomach lining. The distinction matters because many people who safely take a baby aspirin every day assume the drug is inherently gentle. At arthritis doses, it is not.
Stomach and Bleeding Risks
The biggest drawback of long-term aspirin use for arthritis is gastrointestinal damage. Aspirin suppresses COX-1, an enzyme that helps maintain the protective mucus lining of your stomach. Without that protection, the stomach lining becomes vulnerable to erosion, ulcers, and bleeding.
Data from large prevention trials put the risk in perspective. Even at very low doses (100 mg or less daily), aspirin increases the risk of major GI bleeding by about 58%. At the higher doses used for arthritis pain, the risk is at least as high. In real-world terms, that translates to roughly 1 to 2 extra cases of serious GI bleeding per 1,000 people per year of aspirin use. That sounds small in percentage terms, but over years of daily use for a chronic condition like arthritis, the cumulative risk adds up, especially for older adults who are already more prone to GI bleeding.
This is the core reason most doctors now steer arthritis patients toward other options. Drugs like ibuprofen and naproxen carry similar GI risks but tend to be more effective at standard doses. Newer selective anti-inflammatory drugs reduce stomach risk further, though they come with their own trade-offs.
Kidney Concerns
At doses above 325 mg per day, aspirin reduces blood flow through the kidneys in the same way other anti-inflammatory drugs do. For people with healthy kidneys, this is usually manageable. But for anyone with chronic kidney disease, particularly those with an eGFR below 60 (a common measure of kidney function), the National Kidney Foundation recommends avoiding aspirin and similar drugs entirely. Since arthritis and kidney disease both become more common with age, this rules out a significant number of the people who might otherwise consider aspirin for joint pain.
Where Aspirin Fits Today
Aspirin still works as an anti-inflammatory painkiller. The pharmacology hasn’t changed. What has changed is the landscape of alternatives. For osteoarthritis, topical anti-inflammatory gels, acetaminophen, physical therapy, and other oral anti-inflammatories with better-studied safety profiles have pushed aspirin down the list. For rheumatoid arthritis, disease-modifying drugs are the cornerstone of treatment, and aspirin plays no meaningful role in slowing disease progression.
Where aspirin does remain relevant is in people who are already taking low-dose aspirin for heart protection and want to know if it’s helping their joints at all. At 75 to 100 mg, the anti-inflammatory effect is minimal. You’d need to take several times that dose to get meaningful arthritis relief, and that shift in dosing brings a very different risk profile. If you’re managing arthritis pain and already on low-dose aspirin for your heart, adding a separate anti-inflammatory is a conversation worth having, since combining aspirin with ibuprofen can blunt aspirin’s cardiovascular benefits.